PRKAA1 and breast carcinoma: Taken together, these results suggest that doxorubicin treatment induces autophagy to contribute to breast cancer cell apoptosis and that the expression of AMPKα1, which protects against doxorubicin-induced cytotoxicity, is reduced in an autophagy-dependent manner.